Erratum: Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer - Phase I/II study (International Journal of Urology (1995) 2 (281-360))

O. Yoshida; Y. Kakehi; Yoichi Arai; T. Tomoyoshi; Y. Okada; T. Matsuda; O. Mokami; T. Fukuyama; S. Hida; T. Okabe

Erratum: Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer - Phase I/II study (International Journal of Urology (1995) 2 (281-360))

O. Yoshida, Y. Kakehi, Yoichi Arai, T. Tomoyoshi, Y. Okada, T. Matsuda, O. Mokami, T. Fukuyama, S. Hida, T. Okabe

MED - Medical Sciences

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Number of pages	1
Journal	International Journal of Urology
Volume	3
Issue number	1
Publication status	Published - 1996 Jan 1

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Yoshida, O., Kakehi, Y., Arai, Y., Tomoyoshi, T., Okada, Y., Matsuda, T., Mokami, O., Fukuyama, T., Hida, S., & Okabe, T. (1996). Erratum: Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer - Phase I/II study (International Journal of Urology (1995) 2 (281-360)). International Journal of Urology, 3(1).

Erratum: Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer - Phase I/II study (International Journal of Urology (1995) 2 (281-360)). / Yoshida, O.; Kakehi, Y.; Arai, Yoichi et al.
In: International Journal of Urology, Vol. 3, No. 1, 01.01.1996.

Research output: Contribution to journal › Comment/debate › peer-review

Yoshida, O, Kakehi, Y, Arai, Y, Tomoyoshi, T, Okada, Y, Matsuda, T, Mokami, O, Fukuyama, T, Hida, S & Okabe, T 1996, 'Erratum: Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer - Phase I/II study (International Journal of Urology (1995) 2 (281-360))', International Journal of Urology, vol. 3, no. 1.

@article{317049cf66f946fe961dd7183d6059cc,

title = "Erratum: Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer - Phase I/II study (International Journal of Urology (1995) 2 (281-360))",

author = "O. Yoshida and Y. Kakehi and Yoichi Arai and T. Tomoyoshi and Y. Okada and T. Matsuda and O. Mokami and T. Fukuyama and S. Hida and T. Okabe",

year = "1996",

month = jan,

day = "1",

language = "English",

volume = "3",

journal = "International Journal of Urology",

issn = "0919-8172",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer - Phase I/II study (International Journal of Urology (1995) 2 (281-360))

AU - Yoshida, O.

AU - Kakehi, Y.

AU - Arai, Yoichi

AU - Tomoyoshi, T.

AU - Okada, Y.

AU - Matsuda, T.

AU - Mokami, O.

AU - Fukuyama, T.

AU - Hida, S.

AU - Okabe, T.

PY - 1996/1/1

Y1 - 1996/1/1

UR - http://www.scopus.com/inward/record.url?scp=0029886482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029886482&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:0029886482

SN - 0919-8172

VL - 3

JO - International Journal of Urology

JF - International Journal of Urology

IS - 1

ER -

Erratum: Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer - Phase I/II study (International Journal of Urology (1995) 2 (281-360))

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this